The significance of E-cadherin and α-, β-, and γ-catenin expression in surgically treated non-small cell lung cancersof 3 cm or less in size

被引:31
作者
Lee, YC
Wu, CT
Chen, CS
Hsu, HH
Chang, YL
机构
[1] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan
关键词
D O I
10.1067/mtc.2002.119334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Expression of the cell-cell adhesion molecules E-cadherin and alpha-, beta-, and gamma-catenin seems closely related to turner invasiveness. The relationship between the expression and clinicopathologic characteristics in surgically resected non-small cell lung cancers of 3 cm or less in size was studied. The relationship to patient survival was analyzed. Methods: A total of 115 patients with surgically resccted lung cancers of 3 cm or less in size were enrolled in this study. Expression of E-cadherin and alpha-, beta-, and gamma-catenin was immunohistochemically measured. The chi(2) test was used to correlate this expression with clinicopathologic parameters. Their influence on patient survival was evaluated with the Cox proportional hazards model. Results: There was a positive correlation between E-cadherin and catenin expression in lung cancers. In general, E-cadherin and catenin expression were greater in tumors that were either bronchioloalveolar carcinomas or adenocarcinomas, well differentiated, early stage, peripheral, and without vascular or pleural invasion. By using multicovariate analysis of patient survival, only early-stage and peripheral tumors were significantly favorable prognostic factors. Further analysis of the group of patients with early-stage disease showed that higher alpha-, beta-, or gamma-catenin expression was a favorable prognostic indicator. Conclusion: Expression of alpha-, beta-, or gamma-catenin can be used as a prognostic indicator in patients with surgically resected stage I non-small cell lung cancers of 3 cm or less in size.
引用
收藏
页码:502 / 507
页数:6
相关论文
共 26 条
  • [1] α-Catenin expression has prognostic value in local and locally advanced prostate cancer
    Aaltomaa, S
    Lipponen, P
    Ala-Opas, M
    Eskelinen, M
    Kosma, VM
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (3-4) : 477 - 482
  • [2] Clinical significance of α-catenin, collagen IV, and Ki-67 expression in epithelial ovarian cancer
    Anttila, M
    Kosma, VM
    Ji, HX
    Wei-Ling, X
    Puolakka, J
    Juhola, M
    Saarikoski, S
    Syrjanen, K
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2591 - 2600
  • [3] Bracke ME, 1996, CURR TOP MICROBIOL, V213, P123
  • [4] The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer
    Che, XM
    Hokita, S
    Nuruki, K
    Toyoyama, H
    Tanabe, G
    Baba, M
    Takao, S
    Aikou, T
    [J]. SURGERY TODAY, 1998, 28 (06) : 587 - 594
  • [5] DeLeeuw WJF, 1997, J PATHOL, V183, P404, DOI 10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO
  • [6] 2-9
  • [7] E-CADHERIN-MEDIATED CELL CELL-ADHESION PREVENTS INVASIVENESS OF HUMAN CARCINOMA-CELLS
    FRIXEN, UH
    BEHRENS, J
    SACHS, M
    EBERLE, G
    VOSS, B
    WARDA, A
    LOCHNER, D
    BIRCHMEIER, W
    [J]. JOURNAL OF CELL BIOLOGY, 1991, 113 (01) : 173 - 185
  • [8] Harpole DH, 1995, CLIN CANCER RES, V1, P659
  • [9] Hidaka N, 1998, MODERN PATHOL, V11, P1039
  • [10] Hiscox S, 1997, ANTICANCER RES, V17, P1349